novo nordisk news - Search News

Eli Lilly, Novo Nordisk

Hosted on MSN · 3h

Jim Cramer Says Novo Nordisk A/S (NVO) ‘Doesn’t Hold A Candle To Eli Lilly’

We recently published an article titled, Jim Cramer’s Latest Lightning Round: 12 Stocks to Watch. In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against other stocks discussed by Jim Cramer during the latest lightning round.

The Motley Fool on MSN · 1d

Eli Lilly vs. Novo Nordisk: Which Weight Loss Stock is The Better Opportunity Over The Next 10 Years?

The case for Novo Nordisk. Right now Novo Nordisk has a considerable lead on Lilly in GLP-1 market share, and a couple of notable wins have me thinking this lead will widen. Earli

NBC News on MSN · 1d

Eli Lilly to trial use of weight loss drugs to combat unemployment in U.K.

U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K.

Novo, Catalent and FTC

Consumer and labor groups urge FTC to block Catalent sale to Novo Holdings

The coalition said in a letter sent to the FTC Thursday that the deal could reduce access to GLP-1s, and harm competition in development of cell and gene therapies.

Consumer groups ask FTC to block Novo Holdings-Catalent deal

Five U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission on Thursday to block Novo Nordisk's controlling shareholder from acquiring contract drug manufacturer Catalent ,

Pressure Mounts on Novo’s $16.5B Catalent Buy Amid FTC Review

Senator Elizabeth Warren told the Federal Trade Commission that the acquisition of contract manufacturer Catalent could increase Novo’s dominance over the hot GLP-1 market, reducing competition and increasing prices.

12h

Behind the Scenes of Novo Nordisk's Latest Options Trends

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

6d

Wegovy maker Novo Nordisk bets big on talent, AI partnerships in India

Novo Nordisk , whose global profile has risen along with demand for its Wegovy weight-loss drug, is bolstering operations in ...

8d

Novo Nordisk: Mounting Challenges

Novo Nordisk’s stock declined 12% in the past month. Wegovy's sales growth stays under pressure. Read why I'm neutral on NVO ...

15h

Novo Nordisk's Weight Loss Drug Ozempic Associated With Reduced Opioid, Alcohol Use Disorder Incidences, Study Shows

A study found that prescriptions for GIP/GLP-1 RA drugs may reduce opioid overdose and alcohol intoxication rates in patients ...

1d

Novo Nordisk (0QIU) Gets a Hold from Kepler Capital

In a report released on October 15, David Evans from Kepler Capital maintained a Hold rating on Novo Nordisk (0QIU – Research Report), ...

Cyclingnews.com3h

Declan Irvine uses 'pioneer' eating skills to manage diabetes and battle Life Time Grand Prix riders at Big Sugar Gravel

Australian Declan Irvine (Team Novo Nordisk) is a bit wary of the 'big' elements at Big Sugar Gravel this Saturday. He's ...

1don MSN

Is Novo Nordisk A/S (NVO) the Most Promising Biotech Stock According to Hedge Funds?

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds. In this article, we are going ...

Pipeline Report 2024: See the life-changing therapies showing promise

Despite uncertainty around who will sit in The White House in January and what ramifications they may bring, the industry’s ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results